Bozdemir, EnverBalbay, Öner AbidinTerzi, MelekKaplan, Zekeriya2023-07-262023-07-2620211309-3878https://doi.org/10.18521/ktd.905115https://hdl.handle.net/20.500.12684/12829Objective: To guide both the hospital management and the health policymakers who play a role in the management process of their disease by analysing the costs of the patients receiving inpatient treatment in Diizce University Health Application and Research Center (Hospital - DUHARH) due to coronavirus disease 2019 (COVID-19) from the perspective of the Social Security Institution (SSI). Methods: The study covers 582 patients who received inpatient treatment in intensive care and other clinics in March/2020-December/2020 due to COVID-19 disease in DUHARH. In the study, all sample unselected populations were included. Retrospectively obtained data were analysed using bottom-up, document analysis, and multivariate regression analysis. Results: It was determined that 60% of the 582 patients studied were male (350 people), 40% female (232 people) and that the average hospitalization period was 5.7 days, 23% (134 people) in the Pandemic Intensive Care Unit and 77% (448 people) in other pandemic services. The total amount invoiced to SSI by the hospital was 7.378.695,00 TRY ($ 1,052,595). It was determined that 79% of this was the intervention cost and the average daily hospitalization cost per patient was +/- 2,099.80 TRY ($ 299.54). Besides, since gender discrimination is male, elderly patients are hospitalized in intensive care. The hospitalization period is P<0.05. It was observed that medicine, material, intervention, and examination costs have increased. Conclusions: In the study conducted, it was observed that the increase in men, age and hospitalization period, and treatment in intensive care increased the costs, and among these, the intervention costs were the highest. To reduce the cost of illness, it is necessary to use lower-cost factors to eliminate the disease rate with restrictions and ultimately to vaccinate the whole population as soon as possible.en10.18521/ktd.905115info:eu-repo/semantics/openAccessCovid-19; Cost Of Illness; Cost Of Treatment; Cost ManagementTop-DownArticle13421428WOS:000901301900008N/A